Study of OCT Peripapillary Angiography in Patients With Advanced Glaucoma
Recruiting
Observational Study
Glaucoma
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- Nantes University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Glaucoma is a chronic disease of the optic nerve, characterized by progressive loss of nerve cells in the retina, leading to progressive loss of peripheral and central vision. There are in fact several types of glaucoma, which is the world's second leading cause of blindness after cataracts, and the leading cause of irreversible blindness.
To date, to our knowledge, there is no work analyzing the…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men and women aged 18 and over
* Patient with glaucoma followed in the ophthalmology department of Nantes University Hospital
* mean visual field deficit (MD) \>10dB
Exclusion Criteria:
* Retinal vascular pathology (moderate to severe non-proliferative diabetic retinopathy, …
Contacts